Paratek Pharmaceuticals to be Acquired by Gurnet Point Capital and Novo Holdings streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Commercial-stage biopharmaceutical company Paratek Pharmaceuticals Inc. said Tuesday that it will become a private company after agreeing to a purchase by Gurnet Point Capital and Novo Holdings A/S in a deal valued at roughly $462 million and steered by three firms.
/PRNewswire/ Corium Pharma Solutions, Inc. (CPSI), a leading, full-service contract development and manufacturing organization specializing in novel drug.